Podcast terbaik Evaluating Biopharma (2024)

1
Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance 16:49

18d ago16:49

16:49

In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data provenance—why they matter and how the industry can achieve them. With 30 years of experience, Endicott has a deep understanding of training AI and ML models, particularly when patien…

1
Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech 35:01

2M ago35:01

35:01

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Chris Major, founder and partner of BioProcess360 Partners, discuss the best ways to start a company to address technology gaps, why it is beneficial to collaborate with competitors (instead of going against each other), and the challenges encountered when planning to de-risk port…

1
Episode: 21 - How AI is Changing the Antibody R&D Game 31:35

3M ago31:35

31:35

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Tony Arulanandam, SVP and head of R&D at Cytovia Therapeutics, discuss how AI is impacting the antibody R&D field, how companies are using AI to generate better sequences and improve efficacy, and methods on approaching regulators and tackling regulatory challenges. Arulanandam al…

1
Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix 19:38

4M ago19:38

19:38

In this month’s special episode of Evaluating Biopharma, host Ben Locwin interviews Mara Strandlund, chief people officer at National Resilience, and Niamh Alix, chief human resources officer at Prime Medicine, about the upcoming Talent in Biopharma Leadership workshop at the 2024 Bioprocessing Summit. Their conversation covers a wide variety of to…

1
Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies 17:20

6M ago17:20

17:20

In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and gene therapies and what sets them apart from other therapeutics in terms of their processes. Vives also talks about the top characteristics of good starting materials and particular…

1
Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts 23:56

7M ago23:56

23:56

In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about bispecific antibodies. Dr. Schmidt goes into detail about current trends (from a CRO’s perspective) regarding the discovery and development phases of bispecific antibodies, why they are being made, and potential manufacturing issues. He…

1
Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin 22:56

9M ago22:56

22:56

In this episode of Evaluating Biopharma, host Ben Locwin and Jamie Martin, PMP, senior consultant at Black Diamond Networks, discuss the tips and tricks of successful program management. Martin shares his mental checklist of must-haves to ensure a successful start, techniques on what to do when things fall off-track, and the keys to continuous succ…

1
Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma 21:21

9M ago21:21

21:21

In this episode of Evaluating Biopharma, host Ben Locwin speaks with Brian Tham, principal consultant at Peregrine Bio, LLC, on how various projects are run in the pharmaceutical industry, how to improve the outcome and processes of projects, and how to continue improving processes and operational excellence. They also delve into the history of how…

1
Episode: 15 - Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa 19:42

10M ago19:42

19:42

In this month’s episode of Evaluating Biopharma, host Ben Locwin speaks with Nesredin Mussa, PhD, president of Dynamica Biologics, about navigating the challenges of securing successful CDMO-sponsor relationships for a rare disease manufacturing and testing paradigm, the key contributing factors that may pose within the partnership between the spon…

1
Episode: 14 - Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt 16:08

1y ago16:08

16:08

rocess intensification can be an overwhelming experience. In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about strategies and approaches that can help you understand and figure out how to navigate process intensification. Schmidt discusses ways to produce consistent results while using di…

1
Episode: 13 - Identifying Impurities In Gene Therapy With Santoshkumar Khatwani 19:38

1y ago19:38

19:38

In this episode of Evaluating Biopharma, host Ben Locwin speaks with Santoshkumar Khatwani, Director – Analytical Development, Late-Stage CMC Analytical Team Lead at Sangamo Therapeutics, about impurities in gene therapy processes and the ways to identify them. Khatwani discusses how to determine if these impurities are from the product, the proces…

1
Episode: 12 - The Risks and Rewards of Speed-to-IND Strategies With Susan Jones 19:32

1y ago19:32

19:32

What are some strategies that companies can use to get to IND filing quickly? In this brand new conversation, Evaluating Biopharma podcast host Ben Locwin discusses the risks and rewards of speed-to-IND strategies with Susan Jones, Chief Technology Officer at Tourmaline Bio. Susan delves into her 30 years of experience in the biotech industry, how …

1
Episode: 11 - Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy 21:49

1+ y ago21:49

21:49

In this episode of Evaluating Biopharma, host Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Jonathan Tsang, Senior Director, Manufacturing Sciences & Technology at Kite Pharma, who shares his experiences and provides advice on how autologous cell therapy companies can better prepare for commercial manufactur…

1
Episode: 10 - Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business 22:43

1+ y ago22:43

22:43

In this episode of Evaluating Biopharma, Mike Kelly, Senior Vice President at Atsena Therapeutics, shares his experiences and provides his advice on how your company can make proper CMC investments to reduce risk and maximize ROI, including: the make or buy decision, ensuring CMC investment to provide regulators what they need, scalability consider…

1
Episode: 9 - Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy 24:32

1+ y ago24:32

24:32

In this episode of Evaluating Biopharma, Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Susan D'Costa, Chief Technology Officer at Alcyone Therapeutics, who shares her experiences and provides advice on how your company can identify and overcome CMC challenges in gene therapy, including: understanding and mon…

1
Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy 20:08

1+ y ago20:08

20:08

Joseph Shultz, VP and technical head of biologics and vaccines at Resilience, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss the financial considerations biopharma companies face when implementing a continuous strategy. Shultz talks about the mindset of the senior leadership at…

1
Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy 27:22

1+ y ago27:22

27:22

Marty Giedlin, vice president and head of technology operations at Senti Bio, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, to share his experiences and provide advice on how allogeneic cell therapy companies can implement better manufacturing strategies. He discusses understanding and managing man…

1
Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing 19:15

2y ago19:15

19:15

Arthi Narayanan, innovation team leader of pharma technical operations at Genentech, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss how process analytical technology, artificial intelligence, and machine learning support intensified bioprocessing and improve inefficiencies. Nar…

1
Episode: 05 - Navigating Scale-Up Challenges in Protein Production 20:45

2y ago20:45

20:45

Parrish Galliher, an independent bioprocess consultant, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the context-dependent issues that arise when scaling-up protein production. Gallaher uses a case study involving scaling challenges in E. coli bioprocesses that produced a product at 50% pote…

1
Episode 4: Anticipating Disruptions: Identifying and Planning for Shortages 19:42

2y ago19:42

19:42

In the biopharma space, nearly every moving part is contingent upon a functioning supply chain. In this month’s episode, moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, speaks with Rich Musa, director and head of supply chain at Cipla Therapeutics, about anticipating supply chain disruptions and planning for sho…

1
Episode: 3 - Cell and Gene Therapy: Managing the ‘Build or Buy’ Decision 22:36

2y ago22:36

22:36

Dave Backer, founder of DB Biologics and former chief commercial officer at Oxford Biomedica, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the complex business and technological decisions companies face when navigating supply chain issues in the cell and gene therapy (CGT) market. Today’s co…

1
Episode: 2 - Operational Efficiencies: Lower Operational Costs by Reducing Clinical GMP Sampling 25:12

2y ago25:12

25:12

In this episode, Josefine Persson, Genentech associate director, and Ben Locwin, Black Diamond Networks vice president of project solutions, discuss how the cost of oversampling from clinical GMP runs versus development sources equates to high expenses and lost opportunities in moving a new project into GMP manufacturing. Persson also talks about t…

1
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection 21:53

2y ago21:53

21:53

In the inaugural episode of Evaluating Biopharma podcast, CPI’s Simon Hawdon speaks with Moderator John Bonham-Carter about the benefits of converting from batch to continuous processing and the critical decisions involved in making a high-quality product. Hawdon talks about whether there is an optimal time for process conversion, key equipment fea…

1
Episode 000: Introducing the Evaluating Biopharma Podcast 2:07

2y ago2:07

2:07

Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary informati…

Podcast Berbaloi untuk Didengar

Podcast Evaluating Biopharma

Podcast Berbaloi untuk Didengar

1
Evaluating Biopharma

Evaluating Biopharma

1
Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance 16:49

1
Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech 35:01

1
Episode: 21 - How AI is Changing the Antibody R&D Game 31:35

1
Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix 19:38

1
Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies 17:20

1
Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts 23:56

1
Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin 22:56

1
Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma 21:21

1
Episode: 15 - Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa 19:42

1
Episode: 14 - Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt 16:08

1
Episode: 13 - Identifying Impurities In Gene Therapy With Santoshkumar Khatwani 19:38

1
Episode: 12 - The Risks and Rewards of Speed-to-IND Strategies With Susan Jones 19:32

1
Episode: 11 - Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy 21:49

1
Episode: 10 - Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business 22:43

1
Episode: 9 - Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy 24:32

1
Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy 20:08

1
Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy 27:22

1
Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing 19:15

1
Episode: 05 - Navigating Scale-Up Challenges in Protein Production 20:45

1
Episode 4: Anticipating Disruptions: Identifying and Planning for Shortages 19:42

1
Episode: 3 - Cell and Gene Therapy: Managing the ‘Build or Buy’ Decision 22:36

1
Episode: 2 - Operational Efficiencies: Lower Operational Costs by Reducing Clinical GMP Sampling 25:12

1
Episode 001: The Continuous Learning Curve: CPI’s Simon Hawdon on Process Conversion, Product Quality, and Platform Selection 21:53

1
Episode 000: Introducing the Evaluating Biopharma Podcast 2:07

Panduan Rujukan Pantas